Clinical, Biochemical and Outcome Profile of Biotinidase Deficient Patients from Tertiary Centre in Northern India.

INTRODUCTION Biotinidase deficiency is an inherited metabolic disorder with estimated birth incidence of 1 in 61,000 for profound and partial deficiency. Estimated incidence of profound and partial biotinidase deficiency is 1 in 1, 37,000 and 1 in 1, 10,000 respectively. The carrier frequency in general population is 1 in 120. We attempt to study clinical, biochemical and outcome from 10 Biotinidase deficient patients. MATERIALS AND METHODS A retrospective case record study was conducted to record Clinical, biochemical and outcome profile from genetic records. Biotinidase level was measured using spectrophotometric method. RESULTS Study group comprised of 8 males and 2 females with median age of presentation 6 (2-45.75) months. Median (interquartile range) Biotinidase level in study group 0.3 (0.08-1.5) nmol/ml/min. Study group was further divided in to early onset group (< 12 months, n-6) and late onset group (> 12 months, n-4). Seizure, alopecia and hearing loss were predominant phenotypes in study group. The other rare presentations were: hypotonia, ataxia, skin rash, seborrhoea. The most common seizure type was focal seizure. Control of seizure activity was important immediate outcome measured in study group. Median duration (interquartile range) of seizure control in early onset group was 3 (2-4)days against 13.5 (12.25-14.75) days in late onset group. CONCLUSION This study highlights the need of early diagnosis for favourable outcome for a potentially treatable inherited metabolic disorder.

[1]  B. Wolf.  Why screen newborns for profound and partial biotinidase deficiency? , 2015, Molecular genetics and metabolism.

[2]  S. Jabbehdari,et al.  Biotinidase Deficiency: A Reversible Neurometabolic Disorder (An Iranian Pediatric Case Series) , 2013, Iranian journal of child neurology.

[3]  Y. L. Loukas,et al.  High incidence of partial biotinidase deficiency cases in newborns of Greek origin. , 2013, Gene.

[4]  S. Kapoor,et al.  National newborn screening program — Still a hype or a hope now? , 2013, Indian Pediatrics.

[5]  D. Crockett,et al.  The Biotinidase Gene Variants Registry: A Paradigm Public Database , 2013, G3: Genes, Genomes, Genetics.

[6]  B. Wolf.  Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have” , 2012, Genetics in Medicine.

[7]  T. Cowan,et al.  Technical standards and guidelines for the diagnosis of biotinidase deficiency , 2010, Genetics in Medicine.

[8]  B. Wolf.  Clinical issues and frequent questions about biotinidase deficiency. , 2010, Molecular genetics and metabolism.

[9]  Xuefan Gu,et al.  Diagnosis, treatment, follow-up and gene mutation analysis in four Chinese children with biotinidase deficiency , 2009, Journal of Inherited Metabolic Disease.

[10]  M. Rathi,et al.  Biotinidase deficiency with hypertonia as unusual feature. , 2009, Indian pediatrics.

[11]  T. Coşkun,et al.  Audiologic findings in children with biotinidase deficiency in Turkey. , 2007, International journal of pediatric otorhinolaryngology.

[12]  B. Wolf.  Worldwide survey of neonatal screening for biotinidase deficiency , 1991, Journal of Inherited Metabolic Disease.

[13]  A. R. R. Devi,et al.  Newborn screening in India , 2004, Indian journal of pediatrics.

[14]  S. Weremowicz,et al.  Localization of serum biotinidase (BTD) to human chromosome 3 in band p25. , 1994, Genomics.

[15]  B. Wolf,et al.  Biotinidase Deficiency a , 1985, Advances in pediatrics.

[16]  E. Shapira.  Biochemical genetics : a laboratory manual , 1989 .

[17]  H. Wood,et al.  Purification of biotinidase from human plasma and its activity on biotinyl peptides. , 1985, Biochemistry.

[18]  B. Wolf,et al.  Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. , 1983, Clinica chimica acta; international journal of clinical chemistry.